These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6993682)

  • 1. Quantitative structure-pharmacokinetic relationships derived on antibacterial sulfonamides in rats and its comparison to quantitative structure-activity relationships.
    Seydel JK; Trettin D; Cordes HP; Wassermann O; Malyusz M
    J Med Chem; 1980 Jun; 23(6):607-13. PubMed ID: 6993682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative relationships between structure and pharmacokinetic parameters using molecular connectivity chi indices I: Substituted 2-sulfapyridines.
    Reed K; Mereish K; Jensen B
    J Pharm Sci; 1984 Feb; 73(2):237-40. PubMed ID: 6707891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of a series of 6-chloro-2,3,4,5-tetrahydro-3-substituted-1H- 3-benzazepines in rats. Determination of quantitative structure-pharmacokinetic relationships.
    Gombar CT; Demarinis RM; Wise M; Mico BA
    Drug Metab Dispos; 1988; 16(3):367-72. PubMed ID: 2900727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure--pharmacokinetic relationship of a series of sulfonamides in the rat.
    Kaul S; Ritschel WA
    Eur J Drug Metab Pharmacokinet; 1990; 15(3):211-7. PubMed ID: 2253651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-pharmacokinetics relationship of quaternary ammonium compounds. Correlation of physicochemical and pharmacokinetic parameters.
    Neef C; Meijer DK
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):111-8. PubMed ID: 6527701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-pharmacodynamic-pharmacokinetic relationships of steroidal neuromuscular blocking agents.
    Wierda JM; Proost JH
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():45-54. PubMed ID: 8557006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust assessment of statistical significance in the use of unbound/intrinsic pharmacokinetic parameters in quantitative structure-pharmacokinetic relationships with lipophilicity.
    Davis AM; Webborn PJ; Salt DW
    Drug Metab Dispos; 2000 Feb; 28(2):103-6. PubMed ID: 10640503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonidine and related analogues. Quantitative correlations.
    Rouot B; Leclerc G; Wermuth CG
    J Med Chem; 1976 Aug; 19(8):1049-54. PubMed ID: 9510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-pharmacokinetic relationships among the N1,N3-alkylxanthines in rats.
    Apichartpichean R; Hasegawa T; Nadai M; Kuzuya T; Nabeshima T
    J Pharm Pharmacol; 1991 Apr; 43(4):262-9. PubMed ID: 1676739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of drugs. XI. Relation of structure to the bacteriostatic activity of sulfonamides. (2).
    Morishita T; Yamazaki M; Kakeya N; Kamada A; Aoki M
    Chem Pharm Bull (Tokyo); 1970 Apr; 18(4):708-14. PubMed ID: 4913864
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of physicochemical and structural properties on the pharmacokinetics of a series of alpha1L-adrenoceptor antagonists.
    Betts A; Atkinson F; Gardner I; Fox D; Webster R; Beaumont K; Morgan P
    Drug Metab Dispos; 2007 Aug; 35(8):1435-45. PubMed ID: 17502340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships between antibacterial activities and physicochemical properties of sulfonamides.
    Mengelers MJ; Hougee PE; Janssen LH; Van Miert AS
    J Vet Pharmacol Ther; 1997 Aug; 20(4):276-83. PubMed ID: 9280367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure--activity relationships and carminative activity II: steric considerations.
    Evans BK; James KC; Luscombe DK
    J Pharm Sci; 1979 Mar; 68(3):370-1. PubMed ID: 423132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the antibacterial activity towards Escherichia coli NCTC 5933 and the physico-chemical properties of some esters of 3,4,5-trihydroxybenzoic acid (Gallic acid).
    Boyd I; Beveridge EG
    Microbios; 1979; 24(97-98):173-84. PubMed ID: 43458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.
    Hinderling PH; Schmidlin O; Seydel JK
    J Pharmacokinet Biopharm; 1984 Jun; 12(3):263-87. PubMed ID: 6150103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and quantitative structure--activity relationships of some antibacterial 3-formylrifamycin SV N-(4-substituted phenyl)piperazinoacethydrazones.
    Kiritsy JA; Yung DK; Mahony DE
    J Med Chem; 1978 Dec; 21(12):1301-7. PubMed ID: 722738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-pharmacokinetic relationships for systemic drug distribution kinetics not confined to a congeneric series.
    Herman RA; Veng-Pedersen P
    J Pharm Sci; 1994 Mar; 83(3):423-8. PubMed ID: 8207695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-pharmacokinetic relationships in a series of short fatty acid amides that possess anticonvulsant activity.
    Haj-Yehia A; Bialer M
    J Pharm Sci; 1990 Aug; 79(8):719-24. PubMed ID: 2231336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between pharmacokinetic data in cerebral tissue and the lipophilic nature of sulfonamides in the rat].
    Biagi GL; Cantelli Forti G; Rossi T
    G Ital Chemioter; 1979; 26(1-2):219-22. PubMed ID: 554812
    [No Abstract]   [Full Text] [Related]  

  • 20. [Estimation of protein binding by means of the HMO-LCAO-method (author's transl)].
    Schultz OE; Gottfried W
    Arzneimittelforschung; 1976; 26(1):1-5. PubMed ID: 947164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.